The role of HPV type in Recurrent Respiratory Papillomatosis

International Journal of Pediatric Otorhinolaryngology

Volumn 74, Issue 1, 2010, Pages 7-14

  Donne, A J ^a   Hampson, L ^b   Homer, J J ^c   Hampson, I N ^b  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

HPV11; HPV6; Human Papillomavirus (HPV); Recurrent Respiratory Papillomatosis

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; PROTEIN E6; PROTEIN E7; VIRUS DNA;

CARCINOGENICITY; DIAGNOSTIC VALUE; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; LARYNX CARCINOMA; LARYNX PAPILLOMATOSIS; LUNG CARCINOMA; MALIGNANT TRANSFORMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT RESPIRATORY PAPILLOMATOSIS; RELIABILITY; RESPIRATORY TRACT DISEASE; REVIEW; TONSIL CARCINOMA; TRACHEOSTOMY; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS TYPING; VIRUS VIRULENCE;

CONDYLOMATA ACUMINATA; GENOME; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; LARYNGOSTENOSIS; ONCOGENIC VIRUSES; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PAPILLOMA; RECURRENCE; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; TRACHEOSTOMY;

EID: 72749105121     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2009.09.004     Document Type: Review

References (97)

1. Wiatrak B.J., Wiatrak D.W., Broker T.R., et al. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114 11 Pt 2 (Suppl 104) (2004) 1-23
2. de Villiers E.M. Papillomavirus and HPV typing. Clin. Dermatol. 15 March (2) (1997) 199-206
3. Bernard H.U., Chan S.Y., Manos M.M., et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170 November (5) (1994) 1077-1085
4. Bernard H.U., Calleja-Macias I.E., and Dunn S.T. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int. J. Cancer 118 March (5) (2006) 1071-1076
5. de Villiers E.M., Fauquet C., Broker T.R., et al. Classification of papillomaviruses. Virology 324 June (1) (2004) 17-27
6. Ullman E.V. On the aetiology of laryngeal papilloma. Acta Otolaryngol. 5 (1923) 317
7. Gabbott M., Cossart Y.E., Kan A., et al. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J. Clin. Microbiol. 35 December (12) (1997) 3098-3103
8. Pou A.M., Rimell F.L., Jordan J.A., et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann. Otol. Rhinol. Laryngol. 104 October (10 Pt 1) (1995) 758-762
9. Duggan M.A., Lim M., Gill M.J., et al. HPV DNA typing of adult-onset respiratory papillomatosis. Laryngoscope 100 June (6) (1990) 639-642
10. Gissmann L., Wolnik L., Ikenberg H., et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. U.S.A. 80 January (2) (1983) 560-563
11. Mounts P., Shah K.V., and Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. U.S.A. 79 September (17) (1982) 5425-5429
12. Major T., Szarka K., Sziklai I., et al. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J. Clin. Pathol. 58 January (1) (2005) 51-55
13. Pignatari S., Smith E.M., Gray S.D., et al. Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann. Otol. Rhinol. Laryngol. 101 May (5) (1992) 408-412
14. Smith E.M., Pignatari S.S., Gray S.D., et al. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Arch. Otolaryngol. Head Neck Surg. 119 May (5) (1993) 554-557
15. Asadurian Y., Kurilin H., Lichtig H., et al. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J. Med. Virol. 79 November (11) (2007) 1751-1760
16. Zehbe I., Mytilineos J., Wikstrom I., et al. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum. Immunol. 64 May (5) (2003) 538-542
17. Heinzel P.A., Chan S.Y., Ho L., et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J. Clin. Microbiol. 33 July (7) (1995) 1746-1754
18. Kammer C., Tommasino M., Syrjanen S., et al. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br. J. Cancer 86 January (2) (2002) 269-273
19. Rubben A., Beaudenon S., Favre M., et al. Rearrangements of the upstream regulatory region of human papillomavirus type 6 can be found in both Buschke-Lowenstein tumours and in condylomata acuminata. J. Gen. Virol. 73 December (Pt 12) (1992) 3147-3153
20. Draganov P., Todorov S., Todorov I., et al. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int. J. Pediatr. Otorhinolaryngol. 70 March (3) (2006) 469-473
21. Penaloza-Plascencia M., Montoya-Fuentes H., Flores-Martinez S.E., et al. Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 126 September (9) (2000) 1119-1123
22. Dickens P., Srivastava G., Loke S.L., et al. Human papillomavirus 6,11, and 16 in laryngeal papillomas. J. Pathol. 165 November (3) (1991) 243-246
23. Nunez D.A., Astley S.M., Lewis F.A., et al. Human papilloma viruses: a study of their prevalence in the normal larynx. J. Laryngol. Otol. 108 April (4) (1994) 319-320
24. Lawton G., Thomas S., Schonrock J., et al. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J. Oral. Pathol. Med. July (21) 6 (1992) 265-269
25. Miller C.S., and Johnstone B.M. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral. Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91 June (6) (2001) 622-635
26. Zhang Z.Y., Sdek P., Cao J., et al. Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa. Int. J. Oral. Maxillofac. Surg. 33 January (1) (2004) 71-74
27. Sun J.D., Weatherly R.A., Koopmann Jr. C.F., et al. Mucosal swabs detect HPV in laryngeal papillomatosis patients but not family members. Int. J. Pediatr. Otorhinolaryngol. 53 June (2) (2000) 95-103
28. Lacey C.J. Therapy for genital human papillomavirus-related disease. J. Clin. Virol. 32 March (Suppl 1) (2005) S82-S90
29. Vandepapeliere P., Barrasso R., Meijer C.J., et al. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J. Infect. Dis. 192 December (12) (2005) 2099-2107
30. Jenson A.B., Kurman R.J., and Lancaster W.D. Tissue effects of and host response to human papillomavirus infection. Dermatol. Clin. 9 April (2) (1991) 203-209
31. Ji H.X., Syrjanen S., Syrjanen K., et al. In situ hybridization analysis of HPV DNA in cervical precancer and cervical cancers from China. Arch. Gynecol. Obstet. 247 1 (1990) 21-29
32. Ghaffari S.R., Sabokbar T., Mollahajian H., et al. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac. J. Cancer Prev. 7 October (4) (2006) 529-532
33. Cole R.R., Myer III C.M., and Cotton R.T. Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck 11 May (3) (1989) 226-230
34. Stern Y., McCall J.E., Willging J.P., et al. Spontaneous respiration anesthesia for respiratory papillomatosis. Ann. Otol. Rhinol. Laryngol. 109 January (1) (2000) 72-76
35. Shapiro A.M., Rimell F.L., Shoemaker D., et al. Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children's Hospital of Pittsburgh experience. Ann. Otol. Rhinol. Laryngol. 105 January (1) (1996) 1-5
36. Derkay C.S. Task force on recurrent respiratory papillomas. A preliminary report. Arch. Otolaryngol. Head Neck Surg. 121 December (12) (1995) 1386-1391
37. Broker T.R., Jin G., Croom-Rivers A., et al. Viral latency - the papillomavirus model. Dev. Biol. (Basel) 106 (2001) 443-451
38. Stern Y., Felipovich A., Cotton R.T., et al. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study. Ann. Otol. Rhinol. Laryngol. 116 March (3) (2007) 169-171
39. Dartmann K., Schwarz E., Gissmann L., et al. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology 151 May (1) (1986) 124-130
40. Ho L., Chan S.Y., Burk R.D., et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67 November (11) (1993) 6413-6423
41. Yamada T., Wheeler C.M., Halpern A.L., et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69 December (12) (1995) 7743-7753
42. Yamada T., Manos M.M., Peto J., et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71 March (3) (1997) 2463-2472
43. Uversky V.N., Roman A., Oldfield C.J., et al. Protein Intrinsic Disorder and Human Papillomaviruses: Increased Amount of Disorder in E6 and E7 Oncoproteins from High Risk HPVs. J. Proteome. Res. 5 August (8) (2006) 1829-1842
44. Ristriani T., Fournane S., Orfanoudakis G., et al. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Oncogene 28 February (5) (2009) 762-772
45. Hebner C.M., and Laimins L.A. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16 March (2) (2006) 83-97
46. Hummel M., Hudson J.B., and Laimins L.A. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66 October (10) (1992) 6070-6080
47. Morris P.J., Dent C.L., Ring C.J., et al. The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res. 21 February (4) (1993) 1019-1023
48. Chow L.T., Nasseri M., Wolinsky S.M., et al. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61 August (8) (1987) 2581-2588
49. Smotkin D., Prokoph H., and Wettstein F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63 March (3) (1989) 1441-1447
50. Slee E.A., O'Connor D.J., and Lu X. To die or not to die: how does p53 decide?. Oncogene 23 April (16) (2004) 2809-2818
51. Butz K., Denk C., Ullmann A., et al. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl. Acad. Sci. U.S.A. 97 June (12) (2000) 6693-6697
52. Band V., Dalal S., Delmolino L., et al. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J. 12 May (5) (1993) 1847-1852
53. Evans J.N. Recurrent Respiratory Papillomatosis. W. G. Scott-Brown's Otolaryngology. 6th Edition vol. 4 (1996), Butterworth-Heinemann Ltd. 1-5 Chapter 23
54. Doyle D.J., Gianoli G.J., Espinola T., et al. Recurrent respiratory papillomatosis: juvenile versus adult forms. Laryngoscope 104 May (5 Pt 1) (1994) 523-527
55. Benjamin B., and Parsons D.S. Recurrent respiratory papillomatosis: a 10 year study. J. Laryngol. Otol. 102 November (11) (1988) 1022-1028
56. Gerein V., Soldatski I.L., Babkina N., et al. Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation. Int. J. Pediatr. Otorhinolaryngol. 70 December (12) (2006) 2061-2066
57. Lindeberg H., and Elbrond O. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984. Clin. Otolaryngol. Allied. Sci. 15 April (2) (1990) 125-131
58. Gerein V., Rastorguev E., Gerein J., et al. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol. Head Neck Surg. 132 March (3) (2005) 392-394
59. Buchinsky F.J., Donfack J., Derkay C.S., et al. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS ONE 3 5 (2008) e2263
60. Carvalho C.M., Huot L., Charlois A.L., et al. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol. February (2009) 1-9
61. Schneider-Maunoury S., Croissant O., and Orth G. Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J. Virol. 61 October (10) (1987) 3295-3298
62. Choo K.B., Pan C.C., Liu M.S., et al. Presence of episomal and integrated human papillomavirus DNA sequences in cervical carcinoma. J. Med. Virol. 21 February (20 (1987) 101-107
63. Steger G., and Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71 January (1) (1997) 50-58
64. DiLorenzo T.P., Tamsen A., Abramson A.L., et al. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J. Gen. Virol. 73 February (Pt 2) (1992) 423-428
65. Bercovich J.A., Centeno C.R., Aguilar O.G., et al. Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J. Gen. Virol. 72 October (Pt 10) (1991) 2569-2572
66. Zarod A.P., Rutherford J.D., and Corbitt G. Malignant progression of laryngeal papilloma associated with human papilloma virus type 6 (HPV-6) DNA. J. Clin. Pathol. 41 March (3) (1988) 280-283
67. Venuti A., Manni V., Morello R., et al. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J. Med. Virol. 60 April (4) (2000) 396-402
68. Klozar J., Taudy M., Betka J., et al. Laryngeal papilloma - precancerous condition?. Acta Otolaryngol. Suppl. 527 (1997) 100-102
69. Hartley C., Hamilton J., Birzgalis A.R., et al. Recurrent respiratory papillomatosis - the Manchester experience, 1974-1992. J. Laryngol. Otol. 108 March (3) (1994) 226-229
70. Orphanidou D., Dimakou K., Latsi P., et al. Recurrent respiratory papillomatosis with malignant transformation in a young adult. Respir. Med. 90 January (1) (1996) 53-55
71. Solomon D., Smith R.R., Kashima H.K., et al. Malignant transformation in non-irradiated recurrent respiratory papillomatosis. Laryngoscope 95 August (8) (1985) 900-904
72. Matsuba H.M., Thawley S.E., Spector G.J., et al. Laryngeal epidermoid carcinoma associated with juvenile laryngeal papillomatosis. Laryngoscope 95 October (10) (1985) 1264-1266
73. Clifford G.M., Rana R.K., Franceschi S., et al. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev. 14 May (5) (2005) 1157-1164
74. Majoros M., Devine K.D., and Parkhill E.M. Malignant transformation of benign laryngeal papillomas in children after radiation therapy. Surg. Clin. North Am. 43 August (1963) 1049-1061
75. Gorgoulis V., Rassidakis G., Karameris A., et al. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows. Arch. 425 5 (1994) 481-489
76. Lee L.A., Cheng A.J., Fang T.J., et al. High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 118 January (1) (2008) 50-55
77. Lindeberg H., Syrjanen S., Karja J., et al. Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngol. 107 January (1-2) (1989) 141-149
78. Hudelist G., Manavi M., Pischinger K.I., et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92 March (3) (2004) 873-880
79. Matsukura T., Koi S., and Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172 September (1) (1989) 63-72
80. Fuchs P.G., Girardi F., and Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?. Int. J. Cancer 43 January (1) (1989) 41-44
81. Das B.C., Sharma J.K., Gopalakrishna V., et al. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. Gen. Virol. 73 September (Pt 9) (1992) 2327-2336
82. Reidy P.M., Dedo H.H., Rabah R., et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 114 November (11) (2004) 1906-1909
83. Howell R.E., and Gallant L. Human papillomavirus type 16 in an oral squamous carcinoma and its metastasis. Oral. Surg Oral. Med. Oral Pathol. 74 November (5) (1992) 620-626
84. Bouda M., Gorgoulis V.G., Kastrinakis N.G., et al. High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod. Pathol. 13 June (6) (2000) 644-653
85. Abramson A.L., Nouri M., Mullooly V., et al. Latent Human Papillomavirus infection is comparable in the larynx and trachea. J. Med. Virol. 72 March (3) (2004) 473-477
86. McCance D.J., Campion M.J., Clarkson P.K., et al. Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br. J. Obstet Gynaecol. 92 November (11) (1985) 1101-1105
87. Durst M., Gissmann L., Ikenberg H., et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. U.S.A. 80 June (12) (1983) 3812-3815
88. Dahlgren L., Dahlstrand H.M., Lindquist D., et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int. J. Cancer 112 December (6) (2004) 1015-1019
89. Li W., Thompson C.H., O'Brien C.J., et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int. J. Cancer 106 September (4) (2003) 553-558
90. Lindel K., Burri P., Studer H.U., et al. Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. Int. J. Gynecol. Cancer 15 March (2) (2005) 278-284
91. Rimell F.L., Shoemaker D.L., Pou A.M., et al. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope 107 July (7) (1997) 915-918
92. Smith J., Herrero R., Erles K., et al. Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia. Int. J. Cancer 94 November (4) (2001) 520-526
93. Mayor H.D., Drake S., Stahmann J., et al. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am. J. Obstet. Gynecol. 126 September (1) (1976) 100-104
94. Hermonat P.L. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res. 54 April (8) (1994) 2278-2281
95. Mounts P., and Kashima H. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope 94 January (1) (1984) 28-33
96. Maloney E.M., Unger E.R., Tucker R.A., et al. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 132 July (7) (2006) 711-715
97. Rabah R., Lancaster W.D., Thomas R., et al. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr. Dev. Pathol. 4 January (1) (2001) 68-72